After a two-week run-in period, participants were randomly assigned in a 1:1 ratio to either the intervention or control condition
Classification: 1 Natural Alkaloids: Atropine, Hyoscine (Scopolamine) 2 Semisynthetic Derivatives: Atropine methonitrate, Homatropine, Hyoscine butyl bromide, Ipratropium bromide, Tiotropium bromide 3 Synthetic Compounds: Mydriatics: Cyclopentolate, Tropicamide (for eye exams pupil dilation) Vesicoselective (urinary): Oxybutynin, Flavoxate, Tolterodine (for overactive bladder) Antiparkinsonian: Trihexyphenidyl (Benzhexol), Procyclidine, Biperiden (for Parkinsons tremor) Antisecretory / Antispasmodics: - Quaternary compounds: Propantheline, Glycopyrrolate, Clidinium - Tertiary amines: Dicyclomine, Pirenzepine, Valethamate Mechanism of Action (MOA): Block muscarinic receptors (M1M5) secretions, GI motility, bronchodilation, mydriasis, tachycardia, and smooth muscle relaxation
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
This context matters when evaluating whether GLP-1 medication is "too expensive." A $300 annual cost (insured + savings card) or even a $5,000 annual cost (LillyDirect cash pay) must be weighed against the downstream medical costs it prevents
Specifically, it is the active ingredient in the following FDA-approved medications from Novo Nordisk: You might also see advertisements for compounded semaglutide, which is not FDA approved for safety and effectiveness